Rezolute Completes $45 Million Investment Round with Full Exercise of $20 Million Option

REDWOOD CITY, Calif., July 24, 2019 (GLOBE NEWSWIRE) — Rezolute, Inc. (“Rezolute”) (OTCQB:RZLT), a clinical stage biopharmaceutical company specializing in the development of transformative therapies targeting metabolic and orphan diseases, announced today that Handok, Inc. (“Handok”) and Genexine, Inc. (“Genexine”), exercised their combined full $20 million option to purchase shares of Rezolute common stock, increasing their […]

Read More

Cloud Container Vulnerabilities Soar, According to Report

Skybox Security releases mid-year update to its 2019 Vulnerability and Threat Trends Report, analyzing what’s shaping the threat landscape so far this year Report Highlights from 2019 H1 Vulnerabilities in cloud containers have increased by 46 percent compared to the same period in 2018 and by 240 percent compared to 2017 Less than 1 percent of […]

Read More

Afya Limited Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

NOVA LIMA, Brazil, July 23, 2019 (GLOBE NEWSWIRE) — Afya Limited, or Afya (Nasdaq: AFYA) today announced the closing of its initial public offering of 15,805,841 Class A common shares at a public offering price of $19.00 per share. Afya issued and sold 13,888,887 shares of Class A common shares, which includes the full exercise […]

Read More